Skip to content

Metabolic · compound · regulatory review 2026-10-09

AOD-9604

Growth-hormone fragment studied in metabolic research.

The cited evidence and any approval concern the studied or labeled preparation. Oral, nasal, cosmetic and research-market versions do not inherit product approval or proven efficacy.

Editorial review 2026-10-09. source-curated; clinician review pending.

FDA product
not established
Compounding
not established
Research
investigational
Sport
prohibited

What is AOD-9604?

The fragment is not the same as full-length GH or tesamorelin. Seller “5 mg” is a listing size. Papers talk about metabolism. That is not a proven slimming use.

In plain language

AOD-9604 is a piece of growth hormone studied for metabolic effects in early human and lab work. This source set has no FDA-approved AOD-9604 drug. Listed seller size here is 5 mg.

What the evidence says

For each trial, check who or what was studied, which preparation was used and what the findings support before comparing it with personal reports about individual experiences or seller listings that describe a product but don’t establish that it works.

Regulatory context

Regulatory context; not efficacy evidence

No matched treatment-outcome population.

Reported findings. No benefit claim from this context reference.

Nonresponse. Not reported in reviewed excerpt.

Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.

Limits. Context citations do not fill outcome-evidence gaps.

Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Human trial

AOD9604 human trial safety synthesis · Journal of Endocrinology and Metabolism 2013

893 adults across six trials; mostly otherwise healthy adults with obesity, 2001–2006.

Reported findings. Authors described tolerability broadly comparable with placebo; generally no significant between-group IGF-1 or glucose-tolerance changes; no detected antibodies in selected samples.

Nonresponse. Weight-loss efficacy was not established by this safety synthesis.

Harms. Headache, gastrointestinal events and euphoria occurred. Severe chest tightness during IV treatment and serious diarrhea in an oral study were considered possibly related; an isolated glucose increase was also reported. These body findings conflict with the abstract’s blanket no-related-serious-event summary.

Limits. Longer studies were oral, up to 24 weeks. Findings do not establish subcutaneous or commercial-product safety. Sponsor-linked summary, selected antibody testing and inconsistent adverse-event wording limit interpretation.

Preparation: Controlled AOD9604 study material; oral capsules/tablets and intravenous preparation, not commercial-vial equivalence. Route: oral and short-term intravenous; no subcutaneous cohort

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Regulatory status, dated 2026-10-09

FDA product approval

not established. No US therapeutic product approval is established by this curated source set; other countries and products may differ.

Compounding

not established. Compounded products do not carry FDA product approval; legal eligibility is not established here.

Research

investigational. Animal findings and limited clinical data do not establish a general fat-loss benefit.

Sport

prohibited. WADA S2 lists this growth-hormone fragment.

How long it lasts, how you store it, listed sizes

This entry doesn’t give a duration in hours. No verified formulation-specific human estimate in this source set; no guessed value is supplied.

The units chart uses the 5 mg listing. If your vial is a different mass, type that mass. Do not assume AOD-9604 shares storage with GH secretagogues.

U-100 math for listed AOD-9604 sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.

Micrograms per U-100 unit (100 marks / mL)
Listed vial1 mL liquid2 mL liquid3 mL liquid
5 mg502516.7

Risks and mix-ups already on the record

  • Safety is incomplete; absence of reports does not establish safety.
  • Unknown or incomplete for research formulations; this is not a clearance for use.
  • Unknown or incomplete; do not infer compatibility with medications or other substances.

People using PepBear often log: Existing clinician-directed records, symptoms and dated health measurements. Record missing data; trends do not demonstrate causation.

Sources

  1. Primary evidence or regulator source · checked 2026-10-09
  2. WADA prohibited list · checked 2026-10-09
  3. AOD-9604 study (PubMed 15670133) · checked 2026-10-09

Questions people ask

Is AOD-9604 a legal compounding bulk substance?

This catalog records compounding as not established. Legal eligibility depends on the facts. This page is not a legal opinion.

Why only one vial size?

The vendor file tied to this id currently lists 5 mg. More sizes will appear on the chart when the catalog file lists them.

Related cards

A licensed clinician must interpret the evidence for your situation. This entry provides education, not treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.

Optional merchant comparison

Where to buy AOD-9604

Compare the same identity, formulation and format. Blends, oral products and different variants stay separate. A lower price does not establish product quality or medical suitability.

We earn a commission when you buy through PepStar LLC partner links or codes RICHPEP and PEPBEAR. Merchant listings are separate from the evidence and do not establish product quality or medical suitability.

Other dated listings with incomplete quantity or equivalence verification (2)

Individual listing · equivalence unverified

AOD-9604 product listings. Prices exclude unverified shipping and tax.
Price / savingsProduct / quantityTerms / availabilityAction
Price unavailableProduct subtotal. Shipping and tax excluded where unverified.AOD-9604 (5MG)AscensionFormulation not verified · format not verifiedQuantity not verified. No total mg or price per mg.Listed in stock

50% repeat-use program confirmed. Item eligibility, code and stacking unverified; no coupon included in this price.

Dates and offer terms

Price verified: not verified. Quantity verified: not verified.

Listing observed: Oct 9, 2026. Confirm availability with the seller.

Item terms verified: not verified. Eligibility: unknown. Stacking: unknown.

50% repeat-use coupon program confirmed Oct 9, 2026. Actual code, item exclusions and stacking need confirmation before checkout.

Shipping: not verified; seller charges excluded. Tax: not verified; excluded.

View product: AOD-9604 (5MG) at Ascension (opens new tab)Exact merchant listingPartner customer link (opens new tab)Opens the partner referral page. Choose the exact product there; this is separate from the listing above.
Listing source

listing · Oct 9, 2026

Individual listing · equivalence unverified

AOD-9604 product listings. Prices exclude unverified shipping and tax.
Price / savingsProduct / quantityTerms / availabilityAction
Price unavailableProduct subtotal. Shipping and tax excluded where unverified.AOD 9604 — 5mg / PremiumLimitless Life NootropicsFormulation not verified · format not verifiedQuantity not verified. No total mg or price per mg.Listed in stock
RICHPEP

Coupon terms unverified. Item eligibility and stacking unverified; no coupon included in this price.

Dates and offer terms

Price verified: not verified. Quantity verified: not verified.

Listing observed: Oct 9, 2026. Confirm availability with the seller.

Item terms verified: not verified. Eligibility: unknown. Stacking: unknown.

Shipping: not verified; seller charges excluded. Tax: not verified; excluded.

View product: AOD 9604 — 5mg / Premium at Limitless Life Nootropics (opens new tab)Exact merchant listingPartner customer link (opens new tab)Opens the partner referral page. Choose the exact product there; this is separate from the listing above.
Listing source

listing · Oct 9, 2026